Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Anorexia 5 Neoplasms 4 Weight Loss 2 Pancreatic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Cachexia 2 Breast Neoplasms 2 Sleep Initiation and Maintenance Disorders 1 Neoplasm Metastasis 1 Malnutrition 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Depressive Disorder, Major 1 Depression 1 Body Weight 1 Anorexia Nervosa with Significantly Low Body Weight 1 Advanced Cancer 1

Interventions

Escitalopram 3 Psilocybin 2 Interpersonal Psychotherapy 2 Infliximab 2 Antidepressive Agents 2 abacavir 1 Vortioxetine 1 Venlafaxine Hydrochloride 1 Transcranial Magnetic Stimulation 1 Sugars 1 Saline Solution 1 Mirtazapine 1 Magnetic Resonance Spectroscopy 1 Ketamine 1 Fatty Acids, Omega-3 1 Diagnostic Imaging 1 Desvenlafaxine Succinate 1 Cognitive Behavioral Therapy 1 Citalopram 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Depressive Disorder, Major × Mirtazapine × Clear all

NCT01725048 2017-03-13

NRR

UNC Lineberger Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed

Depressive Disorder, Major, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡